大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/05/14 | 4,231 | 4,416 | 4,230 | 4,389 | +171 | +4.1% | 1,084,500 |
2021/05/13 | 4,243 | 4,268 | 4,195 | 4,218 | -30 | -0.7% | 779,900 |
2021/05/12 | 4,288 | 4,306 | 4,210 | 4,248 | -32 | -0.7% | 753,600 |
2021/05/11 | 4,375 | 4,396 | 4,259 | 4,280 | -104 | -2.4% | 879,600 |
2021/05/10 | 4,323 | 4,391 | 4,323 | 4,384 | +87 | +2% | 624,200 |
2021/05/07 | 4,267 | 4,338 | 4,245 | 4,297 | +38 | +0.9% | 762,500 |
2021/05/06 | 4,276 | 4,309 | 4,247 | 4,259 | +58 | +1.4% | 1,099,100 |
2021/04/30 | 4,195 | 4,231 | 4,182 | 4,201 | -16 | -0.4% | 893,600 |
2021/04/28 | 4,204 | 4,240 | 4,183 | 4,217 | -26 | -0.6% | 785,900 |
2021/04/27 | 4,330 | 4,333 | 4,241 | 4,243 | -69 | -1.6% | 905,300 |
2021/04/26 | 4,294 | 4,335 | 4,262 | 4,312 | -11 | -0.3% | 784,200 |
2021/04/23 | 4,278 | 4,333 | 4,273 | 4,323 | +24 | +0.6% | 737,700 |
2021/04/22 | 4,278 | 4,304 | 4,232 | 4,299 | +55 | +1.3% | 815,300 |
2021/04/21 | 4,231 | 4,254 | 4,195 | 4,244 | -33 | -0.8% | 1,035,200 |
2021/04/20 | 4,329 | 4,335 | 4,269 | 4,277 | -75 | -1.7% | 828,300 |
2021/04/19 | 4,330 | 4,368 | 4,316 | 4,352 | +28 | +0.6% | 578,300 |
2021/04/16 | 4,362 | 4,365 | 4,324 | 4,324 | +13 | +0.3% | 829,000 |
2021/04/15 | 4,379 | 4,386 | 4,311 | 4,311 | -53 | -1.2% | 995,400 |
2021/04/14 | 4,500 | 4,500 | 4,357 | 4,364 | -206 | -4.5% | 1,584,300 |
2021/04/13 | 4,536 | 4,611 | 4,536 | 4,570 | +34 | +0.7% | 678,000 |
2021/04/12 | 4,557 | 4,572 | 4,524 | 4,536 | +20 | +0.4% | 671,500 |
2021/04/09 | 4,525 | 4,565 | 4,484 | 4,516 | +34 | +0.8% | 1,077,700 |
2021/04/08 | 4,570 | 4,572 | 4,475 | 4,482 | -83 | -1.8% | 690,000 |
2021/04/07 | 4,575 | 4,605 | 4,532 | 4,565 | -15 | -0.3% | 610,700 |
2021/04/06 | 4,693 | 4,704 | 4,576 | 4,580 | -86 | -1.8% | 778,100 |
2021/04/05 | 4,702 | 4,715 | 4,646 | 4,666 | -15 | -0.3% | 663,800 |
2021/04/02 | 4,715 | 4,726 | 4,656 | 4,681 | -4 | -0.1% | 471,500 |
2021/04/01 | 4,740 | 4,760 | 4,677 | 4,685 | -2 | ±0% | 641,200 |
2021/03/31 | 4,704 | 4,751 | 4,684 | 4,687 | -72 | -1.5% | 869,300 |
2021/03/30 | 4,837 | 4,838 | 4,722 | 4,759 | -45 | -0.9% | 764,300 |
2021/03/29 | 4,772 | 4,839 | 4,750 | 4,804 | +57 | +1.2% | 1,440,700 |
2021/03/26 | 4,713 | 4,775 | 4,704 | 4,747 | +104 | +2.2% | 893,000 |
2021/03/25 | 4,619 | 4,661 | 4,583 | 4,643 | +83 | +1.8% | 763,700 |
2021/03/24 | 4,661 | 4,687 | 4,551 | 4,560 | -123 | -2.6% | 736,400 |
2021/03/23 | 4,726 | 4,728 | 4,682 | 4,683 | -2 | ±0% | 645,300 |
2021/03/22 | 4,756 | 4,794 | 4,653 | 4,685 | -130 | -2.7% | 864,200 |
2021/03/19 | 4,744 | 4,820 | 4,685 | 4,815 | +67 | +1.4% | 1,180,400 |
2021/03/18 | 4,700 | 4,777 | 4,687 | 4,748 | +70 | +1.5% | 814,400 |
2021/03/17 | 4,647 | 4,690 | 4,618 | 4,678 | -19 | -0.4% | 739,500 |
2021/03/16 | 4,661 | 4,706 | 4,619 | 4,697 | +26 | +0.6% | 942,500 |
2021/03/15 | 4,590 | 4,673 | 4,589 | 4,671 | +86 | +1.9% | 829,000 |
2021/03/12 | 4,494 | 4,590 | 4,452 | 4,585 | +58 | +1.3% | 1,642,700 |
2021/03/11 | 4,591 | 4,591 | 4,492 | 4,527 | -48 | -1% | 1,005,800 |
2021/03/10 | 4,535 | 4,610 | 4,532 | 4,575 | +7 | +0.2% | 823,600 |
2021/03/09 | 4,513 | 4,574 | 4,475 | 4,568 | +144 | +3.3% | 944,100 |
2021/03/08 | 4,396 | 4,468 | 4,374 | 4,424 | +47 | +1.1% | 687,900 |
2021/03/05 | 4,333 | 4,377 | 4,306 | 4,377 | +75 | +1.7% | 854,400 |
2021/03/04 | 4,339 | 4,356 | 4,252 | 4,302 | -19 | -0.4% | 741,100 |
2021/03/03 | 4,308 | 4,333 | 4,261 | 4,321 | +12 | +0.3% | 996,900 |
2021/03/02 | 4,283 | 4,336 | 4,257 | 4,309 | -44 | -1% | 760,900 |
1051~
1100
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 789,300円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 440,200円 | -1.1% | +75.3% | 4.54% | 30.49倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 358,800円 | +6.0% | +4.0% | 2.17% | 22.14倍 | 4.09倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 162,900円 | +0.9% | +380.2% | 4.79% | 22.44倍 | 1.93倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,000円 | +20.9% | +10.6% | 2.60% | 12.01倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム